| Financial Year |
March 31 2023 |
| Monetary Funds |
1,485,558,141.30 |
| Held-for-trading Financial Assets |
131,111,341.09 |
| Notes Receivable |
40,324,486.61 |
| Accounts Receivable |
2,989,786,072.15 |
| Advances to Suppliers |
99,437,471.98 |
| Other Receivables |
83,814,391.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,965,939,457.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
136,601,586.90 |
| Total Current Assets |
7,079,278,252.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,504,493.03 |
| Investment Properties |
-- |
| Fixed Assetes |
2,002,685,914.92 |
| Under-construction Projects |
946,062,795.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
321,111,383.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
460,050,007.76 |
| Deferred Income Tax Assets |
174,924,116.09 |
| Other Non-Current Assets |
227,962,799.59 |
| Sub-Total of Non-Current Assets |
4,294,070,386.64 |
| Total Assets |
11,373,348,639.12 |
| Short-Term Loans |
837,020,577.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
113,379,611.91 |
| Accounts Payable |
2,708,540,035.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
513,478,401.59 |
| Taxes Payable |
40,170,284.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,293,778.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
388,324,644.65 |
| Other Current Liabilities |
2,481,275.02 |
| Sub-Total of Current Liabilities |
4,659,122,459.21 |
| Long-term Loans |
2,320,108,017.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
50,369,595.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,424,229,799.60 |
| Total Liabilities |
7,083,352,258.81 |
| Paid-In Capital(Or Share Stock) |
299,386,862.00 |
| Capital Surplus |
151,312,418.21 |
| Surplus Reserve |
127,199,190.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,573,457,041.00 |
| Minority Stockholder's Interest |
129,481,242.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,160,515,137.88 |
| Owner's Equity（Stockholder's Equity） |
4,289,996,380.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,373,348,639.12 |
